Literature DB >> 7033372

Assay of membrane complement receptors (CR1 and CR2) with C3b- and C3d-coated fluorescent microspheres.

J D Lambris, G D Ross.   

Abstract

A sensitive and specific fluorescence assay for membrane complement (C) receptors (CR1 and CR2) was developed with purified C3b and C3d fragments coupled to fluorescent microspheres (0.9 mu diameter). C3-microspheres (C3-ms) bound to cells with low numbers of receptors that were undetectable by other assay techniques. Inhibition studies with anti-CR1 and anti-CR2 demonstrated that C3b-ms and C3d-ms bound exclusively to CR1 and CR2, respectively. Preparation of the C3-ms required only small amounts of partially purified C3 and no immunoglobulin or other C components. Once formed, the C3-ms were stable for up to 4 mo at 4 degrees C.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7033372

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement.

Authors:  J D Lambris; V S Ganu; S Hirani; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

Review 2.  The chemistry and biology of complement receptors.

Authors:  R D Schreiber
Journal:  Springer Semin Immunopathol       Date:  1984

3.  Autoradiographical demonstration of C3b receptor activity on resident peritoneal macrophages.

Authors:  R de Water; L A Ginsel; W T Daems; M R Daha
Journal:  Histochemistry       Date:  1983

4.  Inhibition of neutrophil function by fluid phase C3b of complement.

Authors:  J D Ogle; C K Ogle; J W Alexander
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

5.  Mapping of the properdin-binding site in the third component of complement.

Authors:  J D Lambris; J Alsenz; T F Schulz; M P Dierich
Journal:  Biochem J       Date:  1984-01-01       Impact factor: 3.857

6.  Molecular basis for complement recognition and inhibition determined by crystallographic studies of the staphylococcal complement inhibitor (SCIN) bound to C3c and C3b.

Authors:  Brandon L Garcia; Kasra X Ramyar; Apostolia Tzekou; Daniel Ricklin; William J McWhorter; John D Lambris; Brian V Geisbrecht
Journal:  J Mol Biol       Date:  2010-07-21       Impact factor: 5.469

7.  Protection of nonself surfaces from complement attack by factor H-binding peptides: implications for therapeutic medicine.

Authors:  You-Qiang Wu; Hongchang Qu; Georgia Sfyroera; Apostolia Tzekou; Brian K Kay; Bo Nilsson; Kristina Nilsson Ekdahl; Daniel Ricklin; John D Lambris
Journal:  J Immunol       Date:  2011-02-21       Impact factor: 5.422

8.  Opsonized streptococcal cell walls cross-link human leukocytes and erythrocytes by complement receptors.

Authors:  K B Pryzwansky; J D Lambris; E K MacRae; J H Schwab
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

9.  Inhibition of the alternative pathway of complement by glomerular chondroitin sulphate proteoglycan.

Authors:  R J Quigg
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

10.  Crystallization of human complement component C3b in the presence of a staphylococcal complement-inhibitor protein (SCIN).

Authors:  Brandon L Garcia; Apostolia Tzekou; Kasra X Ramyar; William J McWhorter; Daniel Ricklin; John D Lambris; Brian V Geisbrecht
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.